Fresenius Medical Care AG & Co. KGaA (FME) Given a €89.00 Price Target at Goldman Sachs Group

Share on StockTwits

Goldman Sachs Group set a €89.00 ($103.49) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report released on Friday. The brokerage currently has a buy rating on the stock.

Several other equities research analysts have also recently commented on FME. HSBC set a €107.00 ($124.42) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Tuesday, August 28th. JPMorgan Chase & Co. set a €97.90 ($113.84) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, August 29th. Barclays set a €87.20 ($101.40) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Friday, August 31st. UBS Group set a €86.00 ($100.00) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Friday, August 31st. Finally, Jefferies Financial Group set a €82.00 ($95.35) price objective on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Tuesday, September 25th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company has an average rating of Buy and an average target price of €87.36 ($101.59).

Fresenius Medical Care AG & Co. KGaA stock opened at €62.24 ($72.37) on Friday. Fresenius Medical Care AG & Co. KGaA has a one year low of €75.53 ($87.83) and a one year high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: NASDAQ

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.